BL
CELG

Balentine LLC’s Celgene Corp CELG Stock Holding History

Balentine LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-214
Closed -$21K – 801
2019
Q3 		$21K Buy
214
+61
+40% +$5.8K ﹤0.01% 230
2019
Q2 		$14K Buy
153
+87
+132% +$8.26K ﹤0.01% 263
2019
Q1 		$6K Buy
+66
New +$5.77K ﹤0.01% 405
2018
Q1 		– Sell
-1,381
Closed -$144K – 632
2017
Q4 		$144K Buy
1,381
+361
+35% +$40.7K 0.01% 157
2017
Q3 		$149K Sell
1,020
-37
-4% -$5.04K 0.01% 140
2017
Q2 		$137K Buy
1,057
+481
+84% +$58.9K 0.01% 131
2017
Q1 		$72K Buy
576
+268
+87% +$32.1K 0.01% 194
2016
Q4 		$36K Buy
308
+47
+18% +$5.23K ﹤0.01% 251
2016
Q3 		$27K Buy
261
+135
+107% +$14.6K ﹤0.01% 238
2016
Q2 		$12K Buy
126
+95
+306% +$9.83K ﹤0.01% 322
2016
Q1 		$3K Sell
31
-442
-93% -$45.5K ﹤0.01% 315
2015
Q4 		$57K Buy
473
+7
+2% +$810 0.01% 148
2015
Q3 		$50K Buy
466
+100
+27% +$12.4K 0.01% 174
2015
Q2 		$42K Sell
366
-103
-22% -$11.8K 0.01% 167
2015
Q1 		$54K Buy
+469
New +$56K 0.01% 134

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Balentine LLC's CELG Position: Q4 2019 in Review

Balentine LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 214 shares — an estimated $21K sold.

Balentine LLC first reported a position in CELG in Q1 2015 and held it in 15 quarters. The position peaked at $149K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Balentine LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Balentine LLC sold 214 Celgene Corp shares in Q4 2019, an estimated $21K.
  • Balentine LLC first reported a position in Celgene Corp in Q1 2015 and held it in 15 quarters.
  • Balentine LLC's Celgene Corp position peaked at $149K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Balentine LLC's 13F filing for Q4 2019, filed 2 Sep 2020.